US Focus on Myeloproliferative Neoplasms (MPN) & Myelodysplastic Syndromes (MDS) 2017
In-Person Event
Aug 04 - 05, 2017
Philadelphia, Pennsylvania, USA
OVERVIEW
US Focus on Myeloproliferative Neoplasms (MPN) and Myelodysplastic Syndromes (MDS) is organized by Imedex LLC and would be held durind Aug 04 - 05, 2017 at Philadelphia Marriott West, Philadelphia, Pennsylvania, United States of America. The target audience for this medical event for Oncologists.
The target audience for this medical event for hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, nurse practitioners, etc.) who are involved and/or interested in the treatment of patients with MPN and MDS. This CME Conference has been approved with a maximum of 9.25 AMA PRA Category 1 Credits.
Conference Objectives are :
• Analyze the role of the molecular and genetic landscape, including the immune system, in the pathogenesis of MPN and MDS.
• Distinguish the underlying mechanisms associated with the development of MPNs and MDS to improve diagnosis, prognosis, and selection of therapeutics.
• Utilize updated diagnostic guidelines, including key revisions, for the management of MPN Describe the challenges of managing MPN or MDS.
• Identify the benefits versus risks of current and emerging therapies for the treatment of MPN and MDS.
• Develop new approaches for the management of MPN and MDS based on recent advances in the field.
Additional details will be posted as soon as they are available.
The target audience for this medical event for hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, nurse practitioners, etc.) who are involved and/or interested in the treatment of patients with MPN and MDS. This CME Conference has been approved with a maximum of 9.25 AMA PRA Category 1 Credits.
Conference Objectives are :
• Analyze the role of the molecular and genetic landscape, including the immune system, in the pathogenesis of MPN and MDS.
• Distinguish the underlying mechanisms associated with the development of MPNs and MDS to improve diagnosis, prognosis, and selection of therapeutics.
• Utilize updated diagnostic guidelines, including key revisions, for the management of MPN Describe the challenges of managing MPN or MDS.
• Identify the benefits versus risks of current and emerging therapies for the treatment of MPN and MDS.
• Develop new approaches for the management of MPN and MDS based on recent advances in the field.
Additional details will be posted as soon as they are available.
KEY DATES
04 Aug, 2017
Event Start Date
05 Aug, 2017
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Philadelphia Marriott WestRELATED CONFERENCES & LIVE WEBINARS
Quick Links